Actavis PLC (NYSE:ACT)

291.36
Delayed Data
As of Feb 27
 +1.58 / +0.55%
Today’s Change
184.71
Today|||52-Week Range
296.77
+13.19%
Year-to-Date

Today’s Trading

Previous close289.78
Today’s open290.10
Day’s range289.86 - 292.62
Volume3,747,630
Average volume (3 months)2,809,037
Market cap$77.2B
Dividend yield--
Data as of 4:03pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+22.50%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.14+0.20%
ABTAbbott Laboratories-0.24-0.50%
AGNAllergan+0.34+0.15%
AZNAstraZeneca-0.11-0.16%
Data as of 4:07pm ET, 02/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$4.05
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account